Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Tracheitis Capsule is a combination pharmaceutical product developed by Shanhaidan Pharmaceutical that integrates Traditional Chinese Medicine (TCM) with Western chemical agents. It is primarily indicated for the treatment of acute and chronic bronchitis, addressing symptoms such as cough, excessive phlegm, and bronchial wheezing. The formulation contains several TCM herbal extracts, including *Fructus Trichosanthis*, *Radix Platycodonis*, *Radix Polygalae*, and *Radix Glycyrrhizae*, which provide natural antitussive and expectorant properties. These are combined with three specific chemical active ingredients: Ephedrine Hydrochloride, which acts as a bronchodilator to relieve airway obstruction; Ammonium Chloride, which serves as an expectorant by increasing respiratory tract fluid; and Chlorpheniramine Maleate, an antihistamine that reduces allergic inflammation and mucus secretion. This multi-component approach is designed to provide comprehensive relief from respiratory distress associated with inflammatory bronchial conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Tracheitis Capsule.